Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy

Clinical trial NCT00283842 · TERMINATED

Trial details

NCT number: NCT00283842
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Neuropathies Pain

Start date: 2006-03-01
Primary completion: 2008-06-01
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.